Hisamitsu Pharmaceutical Co (TSE:4530) Cash Flow from Discontinued Operations : 円0 Mil (TTM As of Aug. 2024)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Hisamitsu Pharmaceutical Co's cash flow from discontinued operations for the three months ended in Aug. 2024 was 円0 Mil. It means Hisamitsu Pharmaceutical Co received 円0 Mil from the sale of part of business quarterly. Hisamitsu Pharmaceutical Co's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Aug. 2024 was 円0 Mil.

Hisamitsu Pharmaceutical Co Cash Flow from Discontinued Operations Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Cash Flow from Discontinued Operations Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Cash Flow from Discontinued Operations

Get a 7-Day Free Trial

Hisamitsu Pharmaceutical Co Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Cash Flow from Discontinued Operations	Get a 7-Day Free Trial															-	-	-	-	-

Hisamitsu Pharmaceutical Co Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

Hisamitsu Pharmaceutical Co Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Cash Flow from Discontinued Operations

Comparable Companies

Traded in Other Exchanges

HTSUY:USA HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co Headlines

No Headlines